Biomarker Tests & Related Drugs

Amyloid Tests

Here are links to some of the newly approved amyloid tests

Blood Tests

Precivity C2N

Roche

Quest **direct to consumer is controversial

CSF

Fujirebio Lumipulse

Roche: Elecsys pTau181/Abeta42, tTau/Abeta42

General: How is Alzheimer's Disease Treated

Amyloid Reducing Drugs

Lecanumab (Leqembi)

FDA Approval and Label and Coverage Determination

Center for Medicare Services statement 

Coverage with Evidence Development (CED) CMS Registry (Entry in Registry)

Appropriate Use Recommendations

Institute for Clinical and Economic Review (ICER) Report

Comments from center, Greg Jicha, MD, Ph.D.

Gantenerumab

Alzforum Review

Aduhelm

Alzheimer's Association and opinion of final decision

Alzheimer's International

Food and Drug Administration 

National Institute on Aging

Center for Medicare and Medicaid Services (CMS)-coverage decision

CMS more detailed information

Consent Guidelines for Treatment

American Academy of Neurology-aducanumab

Opinions from AGREEDementia Members

Developing an Economic and Policy Research Agenda for Blood Biomarkers of Neurodegenerative Diseases

The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA

Other Biomarker Tests

CSF

Alpha-Synuclein (for Parkinson's, Lewy Body Dementia (LBD), AD/LBD, MCI/LBD, Multiple system Atrophy(MSA)

SYNTap